State Street’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $255M | Buy |
|
|||||
|
2025
Q1 | $199M | Sell |
|
|||||
|
2024
Q4 | $170M | Buy |
|
|||||
|
2024
Q3 | $152M | Buy |
|
|||||
|
2024
Q2 | $148M | Buy |
|
|||||
|
2024
Q1 | $167M | Buy |
|
|||||
|
2023
Q4 | $205M | Buy |
|
|||||
|
2023
Q3 | $133M | Sell |
|
|||||
|
2023
Q2 | $122M | Buy |
|
|||||
|
2023
Q1 | $85.3M | Sell |
|
|||||
|
2022
Q4 | $67.4M | Buy |
|
|||||
|
2022
Q3 | $79M | Sell |
|
|||||
|
2022
Q2 | $99.5M | Buy |
|
|||||
|
2022
Q1 | $93.4M | Buy |
|
|||||
|
2021
Q4 | $58.8M | Buy |
|
|||||
|
2021
Q3 | $145M | Buy |
|
|||||
|
2021
Q2 | $162M | Buy |
|
|||||
|
2021
Q1 | $146M | Buy |
|
|||||
|
2020
Q4 | $163M | Sell |
|
|||||
|
2020
Q3 | $88.3M | Sell |
|
|||||
|
2020
Q2 | $104M | Buy |
|
|||||
|
2020
Q1 | $49.7M | Buy |
|
|||||
|
2019
Q4 | $28.3M | Buy |
|
|||||
|
2019
Q3 | $7.55M | Buy |
|